The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 14, 2022

Filed:

Dec. 09, 2019
Applicant:

Merz Pharma Gmbh & Co. Kgaa, Frankfurt am Main, DE;

Inventors:

Juergen Frevert, Berlin, DE;

Fred Hofmann, Schwielowsee, DE;

Michael Schmidt, Potsdam, DE;

Manuela López De La Paz, Liederbach im Taunus, DE;

Daniel Scheps, Potsdam, DE;

Assignee:

MERZ PHARMA GMBH & CO. KGAA, Frankfurt am Main, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/16 (2006.01); C07K 14/33 (2006.01); C12N 15/52 (2006.01); C12N 15/70 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/164 (2013.01); C07K 14/33 (2013.01); C12N 15/52 (2013.01); C12N 15/70 (2013.01); C12Y 304/24069 (2013.01); A61K 38/00 (2013.01); C12Y 304/24068 (2013.01); Y02A 50/30 (2018.01);
Abstract

This invention relates to novel recombinant clostridial neurotoxins exhibiting increased duration of effect and to methods for the manufacture of such recombinant clostridial neurotoxins. These novel recombinant clostridial neurotoxins comprise a random coil domain, and the methods comprise the steps of inserting a nucleic acid sequence coding for a random coil domain into a nucleic acid sequence coding for a parental clostridial neurotoxin and expression of the recombinant nucleic acid sequence comprising the random coil domain-coding sequence in a host cell. The invention further relates to novel recombinant single-chain precursor clostridial neurotoxins used in such methods, nucleic acid sequences encoding such recombinant single-chain precursor clostridial neurotoxins, and pharmaceutical compositions comprising the recombinant clostridial neurotoxin with increased duration of effect.


Find Patent Forward Citations

Loading…